United States Antimony reported Q2 earnings and revenue significantly below analyst expectations and drastically cut its full-year revenue guidance. This substantial miss and outlook revision are driving a sharp decline in the company's stock price, indicating a major negative corporate catalyst.
United States Antimony (UAMY) announced second-quarter results that fell significantly short of analyst estimates, with revenue totaling $7.93 million against a projected $21.7 million, and earnings at breakeven instead of a 1-cent profit. Compounding this disappointment, the company slashed its fiscal 2026 revenue outlook by nearly half, from $125 million to a range of $60 million to $75 million. This drastic revision signals significant operational challenges or a deteriorating market environment, leading to a sharp 25% drop in the stock price. While the CEO pointed to government deliveries as a future positive, the immediate financial performance and outlook cut are major negative catalysts for traders, indicating potential continued downward pressure in the short term despite a maintained 'Buy' rating from HC Wainwright with a reduced price target.